Hélène Mellerio

Hélène Mellerio

Auto-generated profile, based on publicly available information

Hélène Mellerio

Université Paris Cité, Inserm, ECEVE, UMR 1123, Paris, France

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2012 in Pediatrics
Verified
Journal Article
Closed access
PDF file
HMHélène Mellerio
Hélène Mellerio
CACorinne Alberti
Corinne Alberti
CDCéline Druet
Céline Druet
FCFlorence Capelier
Florence Capelier
IMIsabelle Mercat
Isabelle Mercat
CLClaire Lévy-Marchal
Claire Lévy-Marchal
BACKGROUND AND OBJECTIVE: Most of the cardiovascular risk factors strongly associated with obesity and overweight vary with age and gender. However, few reference values are available for healthy European children. Our objective was to establish pediatric reference ranges for waist circumference, systolic and diastolic blood pressures, fasting lipid levels (total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglycerides), glucose, and insulin. METHODS: A representative sample of 1976 healthy French individuals (1004 female participants and 972 male participants) aged 7 to 20 years was used to obtain age- and gender-specific normal ranges for each of the above-listed cardiovascular risk factors, based on the Royston and Wright method. RESULTS: Mean waist circumference increased with age in both genders and was slightly higher in males than in females. Whereas systolic blood pressure increased gradually with age, with the increase being steeper in males than in females, no gender effect was found for diastolic blood pressure, which was therefore modeled after pooling males and females. Total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglyceride values varied little with age and gender. Glucose and insulin levels revealed pubertal peaks, which were sharper in females than in males, reflecting the normal insulin resistance during puberty. CONCLUSIONS: These ranges can be used as references for European children to monitor cardiovascular risk factors and to plan interventions and education programs.

13 September 2019 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
HMHélène Mellerio
Hélène Mellerio
PJPaul Jacquin
Paul Jacquin
NTNelson Trelles
Nelson Trelles
EREnora Le Roux
Enora Le Roux
RBRichard Belanger
Richard Belanger
HDHervé Devilliers
Hervé Devilliers

1 December 2015 in Diabetes & Metabolism
Verified
Journal Article
Closed access
HMH. Mellerio
H. Mellerio
SGS. Guilmin-Crépon
S. Guilmin-Crépon
PJP. Jacquin
P. Jacquin
MLM. Labéguerie
M. Labéguerie
CLC. Lévy-Marchal
C. Lévy-Marchal
CAC. Alberti
C. Alberti

10 May 2022 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
HMHélène Mellerio
Hélène Mellerio
ADAgnès Dumas
Agnès Dumas
CACorinne Alberti
Corinne Alberti
SGSophie Guilmin-Crépon
Sophie Guilmin-Crépon
MGMargaux Gastaldi
Margaux Gastaldi
PJPaul Jacquin
Paul Jacquin

23 April 2025 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
NBNicolas Bougas
Nicolas Bougas
TKTerhi Kangas
Terhi Kangas
KVKatrien Vanthomme
Katrien Vanthomme
José Joaquin MiraJosé Joaquin Mira
José Joaquin Mira
GBGaël Brulé
Gaël Brulé
ADAgnes Dumas
Agnes Dumas
Background: The socioeconomic impact of rare diseases has been mostly studied at the macrolevel, but evidence at the microlevel is lacking, which overshadows health-related social inequalities affecting people with rare diseases, namely, health selection effects. Aim: This study presents an overview of employment and work ability in individuals living with rare diseases, two factors related to health selection effects. Methods: A systematic literature review was conducted using the PRISMA checklist. Three electronic databases, PubMed, Embase, and Web of Science, were searched from 2013 to 2023. Eligible studies needed to investigate at least one work-related outcome measuring employment or work ability in individuals living with rare diseases and to compare it with a control group. Indeed, including only studies with matched or standardized control groups is essential for ensuring the reliability and validity of research findings. Results: Of the 7,694 abstracts identified, 44 studies, including 34 rare diseases, met the inclusion criteria. Administrative databases were used to collect work-related data in 48% of the studies, and 73% of the studies employed matching methods for comparison. Overall, 52% of the studies focused solely on employment, 14% focused solely on work ability and 34% included both categories. Individuals with rare diseases were less likely to be employed or more likely to be unemployed than controls in 68% of the studies and 87% of the studies reported that individuals with rare diseases were more likely to be work disabled. Regarding work ability, 90% of the studies reported more missed work time in cases than in controls, and more perceived impairment at work was found in 100% of the studies. Discussion/conclusion: These results show that individuals with rare diseases tend to have poor work outcomes, but methodological limitations hamper the understanding of health selection effects. Implications for future research and policy-making are discussed.

14 October 2021 in médecine/sciences
Verified
Journal Article
Open access
PDF file
HMHélène Mellerio
Hélène Mellerio
PJPaul Jacquin
Paul Jacquin
EREnora Le Roux
Enora Le Roux
La transition entre la pédiatrie et la médecine pour adultes est une période charnière pour les adolescents et jeunes adultes porteurs d’une maladie chronique : elle comporte un fort risque de rupture du parcours de soins et de dégradation de l’état de santé à court et long termes. Pour accompagner ce passage, plusieurs plateformes de transition ont été créées ces dernières années en France, dans des hôpitaux pédiatriques ou dans les hôpitaux pour adultes. Leur objectif commun est d’être un lieu ressource offrant un accueil physique des jeunes et de leurs parents autour des questions liées à cette transition, ainsi qu’un accès aux informations utiles à leurs besoins de santé globale. Elles travaillent en partenariat étroit avec les services de soins et les associations de patients. Une forte hétérogénéité de fonctionnement et d’offre de soins est observée dans ces structures encore récentes, qu’il convient de multiplier et de pérenniser. Le principal défi à relever dans les prochaines années est de renforcer les partenariats entre pédiatrie et hôpitaux pour adultes afin de baliser au mieux le parcours de soin des jeunes porteurs d’une maladie chronique. The transition of care between pediatric and adult care is a key-period for adolescents with chronic disease, because of the high risk of follow-up loss and of short-term and long-term poorer health. To support transition, platforms of transition have been created in France since several years, implemented in pediatric or adult care structures. Their common objective is to provide a physical reception of adolescents and their parents to share about transition issues, and to inform them about resources to enhance the adolescent’s global health. They tend to work closely with the referent health care providers and the patients’ associations. A large heterogeneity of functioning and health care supply is still observed in these recent structures. Supporting these structures and reinforcing the partnerships between pediatric and adults care remain a challenge.